⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MTVA News
MetaVia Inc. Common Stock
Form 8-K
sec.gov
MTVA
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
Form 8-K
sec.gov
MTVA